<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">32608329</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>08</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>08</Month>
        <Day>17</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1538-0254</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>39</Volume>
            <Issue>14</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Sep</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of biomolecular structure &amp; dynamics</Title>
          <ISOAbbreviation>J Biomol Struct Dyn</ISOAbbreviation>
        </Journal>
        <ArticleTitle>In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme.</ArticleTitle>
        <Pagination>
          <StartPage>5290</StartPage>
          <EndPage>5303</EndPage>
          <MedlinePgn>5290-5303</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/07391102.2020.1787228</ELocationID>
        <Abstract>
          <AbstractText>The recent outbreak of the 2019 novel coronavirus disease (COVID-19) has been proved as a global threat. No particular drug or vaccine has not yet been discovered which may act specifically against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and causes COVID-19. For this highly infectious virus, 3CL-like main protease (3CL<sup>pro</sup>) plays a key role in the virus life cycle and can be considered as a pivotal drug target. Structure-based virtual screening of DrugBank database resulted in 20 hits against 3CL<sup>pro</sup>. Atomistic 100 ns molecular dynamics of five top hits and binding energy calculation analyses were performed for main protease-hit complexes. Among the top five hits, Nafarelin and Icatibant affirmed the binding energy (g_MMPBSA) of -712.94 kJ/mol and -851.74 kJ/mol, respectively. Based on binding energy and stability of protein-ligand complex; the present work reports these two drug-like hits against SARS-CoV-2 main protease.Communicated by Ramaswamy H. Sarma.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Chatterjee</LastName>
            <ForeName>Shilpa</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Biomedical Science, Chosun University, Gwangju, South Korea.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maity</LastName>
            <ForeName>Arindam</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>School of Pharmaceutical Technology, Adamas University, Kolkata, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chowdhury</LastName>
            <ForeName>Suchana</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>BCDA College of Pharmaceutical Technology, Hridaypur, Kolkata, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Islam</LastName>
            <ForeName>Md Ataul</ForeName>
            <Initials>MA</Initials>
            <Identifier Source="ORCID">0000-0001-6286-6262</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Pharmacy and Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences, University of Kwazulu-Natal, Durban, South Africa.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Muttinini</LastName>
            <ForeName>Ravi K</ForeName>
            <Initials>RK</Initials>
            <AffiliationInfo>
              <Affiliation>Immunocure Discovery solution Pvt. Ltd, IKP, Hyderabad, India.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sen</LastName>
            <ForeName>Debanjan</ForeName>
            <Initials>D</Initials>
            <Identifier Source="ORCID">0000-0001-7600-6781</Identifier>
            <AffiliationInfo>
              <Affiliation>BCDA College of Pharmaceutical Technology, Hridaypur, Kolkata, India.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>07</Month>
          <Day>01</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>England</Country>
        <MedlineTA>J Biomol Struct Dyn</MedlineTA>
        <NlmUniqueID>8404176</NlmUniqueID>
        <ISSNLinking>0739-1102</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D011480">Protease Inhibitors</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.4.-</RegistryNumber>
          <NameOfSubstance UI="D010447">Peptide Hydrolases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056004" MajorTopicYN="N">Molecular Dynamics Simulation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010447" MajorTopicYN="N">Peptide Hydrolases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011480" MajorTopicYN="N">Protease Inhibitors</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">cobicistat</Keyword>
        <Keyword MajorTopicYN="N">drug hits</Keyword>
        <Keyword MajorTopicYN="N">icatibant</Keyword>
        <Keyword MajorTopicYN="N">main protease enzyme</Keyword>
        <Keyword MajorTopicYN="N">nafarelin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32608329</ArticleId>
        <ArticleId IdType="doi">10.1080/07391102.2020.1787228</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
